Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Celularity Inc WT (CELUW)

Celularity Inc WT (CELUW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 22,770 K
  • Annual Income, $ -196,300 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 01/07/25
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0126 +98.41%
on 11/06/24
0.0500 -50.00%
on 11/07/24
+0.0102 (+68.92%)
since 10/18/24
3-Month
0.0075 +233.33%
on 10/01/24
0.0500 -50.00%
on 11/07/24
+0.0050 (+25.00%)
since 08/15/24
52-Week
0.0040 +525.00%
on 12/18/23
0.0683 -63.40%
on 12/22/23
+0.0058 (+30.21%)
since 11/17/23

Most Recent Stories

More News
Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter

CELU : 2.77 (+12.60%)
CELUW : 0.0250 (unch)
Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 Million

CELU : 2.77 (+12.60%)
CELUW : 0.0250 (unch)
Celularity Files Appeal Request and Amended Compliance Plan with Nasdaq Hearings Panel

CELU : 2.77 (+12.60%)
CELUW : 0.0250 (unch)
Celularity Provides Corporate Update

CELU : 2.77 (+12.60%)
CELUW : 0.0250 (unch)
Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal

CELU : 2.77 (+12.60%)
CELUW : 0.0250 (unch)
Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Reboundâ„¢ Product from Sequence LifeScience, Inc.

CELU : 2.77 (+12.60%)
CELUW : 0.0250 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar